This is a demo store. No orders will be fulfilled.

Pharmaceuticals and Biotech

  1. 08 Mar 2022  |  North America

    Global Pharmaceuticals Outlook, 2022

    The Digitalization of the Pharmaceuticals Value Chain is Opening up New Growth Opportunities for Stakeholders

    Frost & Sullivan offers an outlook for the global pharmaceuticals market for 2022-2026, including emerging trends and growth opportunities. Prioritizing booster doses over initial dose coverage is negatively impacting the global mitigation of the COVID-19 pandemic, which is resulting in severe implications on health and social and economic well-bei...

    $4,950.00
  2. 30 Apr 2021  |  North America

    US COVID-19 Vaccines and Therapeutics Tracker—Market Insights and Trends, H1 2021

    Agnostic Vaccine Platform Technology Enhancing Future Growth Potential of Participants in the Value Chain

    This study by Frost & Sullivans Healthcare and Life Sciences team provides critical insights into the US COVID-19 vaccines and therapeutics market, including developing vaccines, supply chain considerations, and requirements to manage distribution. The study also identifies actionable and profitable growth opportunities for industry participants. T...

    $2,450.00
  3. 23 Aug 2019  |  South Asia, Middle East & North Africa

    Middle East and North Africa (MENA) Life Sciences Industry Outlook, Forecast to 2020

    Increased Local Manufacturing and Government Spending on Lifestyle Diseases to be Key Driving Factors in 2020

    In this research deliverable, Frost & Sullivan’s analyst team provides bold perspectives and predictions for the Middle East and North Africa (MENA) region’s life sciences industry in 2020. The markets covered include pharmaceuticals, biotechnology, and in-vitro diagnostics. The analysis captures the impact of trends that are expected to transp...

    $4,950.00
  4. 09 Apr 2018  |  North America

    Global Life Sciences Industry Outlook, 2018

    Global Life Sciences Industry to Reach $1.5 T by 2022, Driven by Innovative Google, Amazon, Facebook, Apple (GAFA) Partnerships and R&D IT Investments

    The global life sciences industry is onto a rocking start with the surge in CEO confidence from US tax reforms, rollicking equity markets and strengthening the global economy. Healthcare digitization, democratization creating explosion in patient data, emergence of value-based reimbursement models, and healthcare consumerism shifting the risk from ...

    $4,950.00